Kim Chapman

President & Chief Operating Officer (COO)

With over 30 years of experience in the medical field and 16 years dedicated specifically to clinical research, Kim Chapman is a seasoned leader and founder of a thriving clinical research organization. Throughout a distinguished career which spans across all phases of clinical research, she has developed deep expertise in regulatory compliance, complexities of trial operations, and the evolving landscape of clinical trials while upholding the highest standards of patient safety and data integrity.

As an entrepreneur, Kim successfully launched Frontier Clinical Research in 2016. Since inception, she has grown Frontier into six clinical research sites – building them from the ground up into efficient, compliant, and high-performing operations, including one in her hometown and several others across surrounding communities. This expansion reflects a strong commitment to advancing medical innovation and increasing access to high-quality research opportunities beyond traditional urban centers.

As a leader, Kim currently oversees and manage a team of 20 professionals, fostering a culture of collaboration, integrity, and excellence. She has played a key role in scaling the business by building high-value sponsor and CRO partnerships, developing data-driven pipeline strategies, and designing systems that enable sustainable, and long-term growth. She is particularly passionate about bringing clinical research to underserved populations, ensuring that diverse communities have access to innovative treatments, and the opportunity to participate in advancing healthcare.

Driven by both experience and purpose, Frontier Clinical Research continues to play a vital role of bridging gaps in clinical research access while maintaining the highest standards of quality, results, strict regulatory adherence and patient care – ultimately, creating an environment where both patients and sponsors can place their trust.